Concepedia

Intravenous Bioavailability

Intravenous Bioavailability is a pharmacokinetic parameter that quantifies the fraction of an administered intravenous drug dose that reaches systemic circulation unchanged, serving as the reference standard for comparing bioavailability across alternative routes of administration.

234

Publications

11.7K

Citations

1.1K

Authors

382

Institutions

Publications per year

2017–2026

22

Parents

Publications

234

The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres

Ruxandra Gref, Abraham J. Domb, P. Quellec et al. · Advanced Drug Delivery Reviews · 1995 · 808 citations · Full text

, , +12

The Pharmacokinetics and Hemodynamic Effects of Intravenous and Intramuscular Dexmedetomidine Hydrochloride in Adult Human Volunteers

John B. Dyck, Mervyn Maze, C Haack et al. · Anesthesiology · 1993 · 324 citations · Full text

, , +12

Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous Administration

Roy Bullingham, Scot Monroe, Andrew Nicholls et al. · The Journal of Clinical Pharmacology · 1996 · 318 citations

, , +16

Bioavailability of dexmedetomidine after extravascular doses in healthy subjects

Markku Anttila, Jani Penttilä, Antti Helminen et al. · British Journal of Clinical Pharmacology · 2003 · 301 citations · Full text

, , +16

Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride.

C. E. Cook, A. Robert Jeffcoat, J M Hill et al. · Drug Metabolism and Disposition · 1993 · 261 citations

, , +13

1–5 of 234

Authors

1.1K

  1. RP
    Robert P. Geyer

    Harvard University, United States

    4 publications · 75 citations

    4

    h-index

  2. AF
    Alan Forrest

    University at Buffalo, State University of New York, United States

    4 publications · 204 citations

    4

    h-index

  3. GL
    George L. Drusano

    Albany Medical Center Hospital, United States

    4 publications · 301 citations

    4

    h-index

  4. RG
    Ruxandra Gref

    Centre National de la Recherche Scientifique, France

    3 publications · 1K citations

    3

    h-index

  5. HC
    Harold C. Standiford

    University of Maryland, Baltimore, United States

    3 publications · 192 citations

    3

    h-index

1–5 of 1.1K

Institutions

382

  1. University at Buffalo, State University of New York

    Buffalo, United States

    5 h-index

    12 publications

    506 citations

  2. Harvard University

    Cambridge, United States

    4 h-index

    10 publications

    310 citations

  3. Centre National de la Recherche Scientifique

    Paris, France

    4 h-index

    14 publications

    2.3K citations

  4. Freie Universität Berlin

    Berlin, Germany

    3 h-index

    6 publications

    1.1K citations

  5. Pfizer (United States)

    New York, United States

    3 h-index

    11 publications

    672 citations

  6. Monash University

    Melbourne, Australia

    3 h-index

    9 publications

    181 citations

  7. Leiden University

    Leiden, The Netherlands

    3 h-index

    14 publications

    638 citations

  8. Tianjin University of Traditional Chinese Medicine

    Tianjin, China

    3 h-index

    21 publications

    405 citations

1–8 of 382

Venues

  1. PubMed

    Repository · 19 publications · 706 citations

    15

    h-index

  2. Clinical Pharmacology & Therapeutics

    CPT · 14 publications · 1K citations

    13

    h-index

  3. Antimicrobial Agents and Chemotherapy

    AAC · 13 publications · 596 citations

    12

    h-index

  4. British Journal of Clinical Pharmacology

    BJCP · 10 publications · 841 citations

    10

    h-index

  5. The Journal of Clinical Pharmacology

    9 publications · 641 citations

    9

    h-index

1–5